Lynn Seely - Net Worth and Insider Trading

Lynn Seely Net Worth

The estimated net worth of Lynn Seely is at least $10 Million dollars as of 2024-04-26. Lynn Seely is the Chief Medical Officer of Medivation Inc and owns about 119,708 shares of Medivation Inc (MDVN) stock worth over $10 Million. Details can be seen in Lynn Seely's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lynn Seely has not made any transactions after 2014-10-22 and currently still holds the listed stock(s).

Transaction Summary of Lynn Seely

To

Lynn Seely Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lynn Seely owns 4 companies in total, including Blueprint Medicines Corp () , Myovant Sciences Ltd () , and Medivation Inc () among others .

Click here to see the complete history of Lynn Seely’s form 4 insider trades.

Insider Ownership Summary of Lynn Seely

Ticker Comapny Transaction Date Type of Owner
Blueprint Medicines Corp 2016-04-14 director
Myovant Sciences Ltd 2016-10-26 director & Principal Executive Officer
Medivation Inc 2015-02-17 Chief Medical Officer
Lyell Immunopharma Inc 2021-06-16 director

Lynn Seely Latest Holdings Summary

Lynn Seely currently owns a total of 1 stock. Lynn Seely owns 119,708 shares of Medivation Inc (MDVN) as of October 22, 2014, with a value of $10 Million.

Latest Holdings of Lynn Seely

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MDVN Medivation Inc 2014-10-22 119,708 81.44 9,749,020

Holding Weightings of Lynn Seely


Lynn Seely Form 4 Trading Tracker

According to the SEC Form 4 filings, Lynn Seely has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 10,000 shares on October 22, 2014, which brought Lynn Seely around $495,150.

Insider Trading History of Lynn Seely

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lynn Seely Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Lynn Seely Ownership Network

Ownership Network List of Lynn Seely

No Data

Ownership Network Relation of Lynn Seely


Lynn Seely Owned Company Details

What does Blueprint Medicines Corp do?

Who are the key executives at Blueprint Medicines Corp?

Lynn Seely is the director of Blueprint Medicines Corp. Other key executives at Blueprint Medicines Corp include Principal FAO Michael Landsittel , director & CEO & President Jeffrey W. Albers , and Principal Accounting Officer Ariel Hurley .

Blueprint Medicines Corp () Insider Trades Summary

Over the past 18 months, Lynn Seely made no insider transaction in Blueprint Medicines Corp (). Other recent insider transactions involving Blueprint Medicines Corp () include a net sale of 175,899 shares made by Jeffrey W. Albers , a net sale of 11,217 shares made by Christopher K. Murray , and a net sale of 26,744 shares made by Michael Landsittel .

In summary, during the past 3 months, insiders sold 118,534 shares of Blueprint Medicines Corp () in total and bought 0 shares, with a net sale of 118,534 shares. During the past 18 months, 301,340 shares of Blueprint Medicines Corp () were sold and 1,100 shares were bought by its insiders, resulting in a net sale of 300,240 shares.

Blueprint Medicines Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Blueprint Medicines Corp Insider Transactions

No Available Data

Lynn Seely Mailing Address

Above is the net worth, insider trading, and ownership report for Lynn Seely. You might contact Lynn Seely via mailing address: 501 2nd Street, Suite 211, San Francisco Ca 94107.

Discussions on Lynn Seely

No discussions yet.